HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takaya Shimura Selected Research

Antibodies

9/2017Expression and subcellular localization of AT motif binding factor 1 in colon tumours.
3/2013A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takaya Shimura Research Topics

Disease

24Stomach Neoplasms (Stomach Cancer)
12/2022 - 06/2008
22Neoplasms (Cancer)
06/2022 - 06/2008
7Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 03/2011
5Colonic Neoplasms (Colon Cancer)
02/2022 - 01/2010
5Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2021 - 11/2011
5Crohn Disease (Crohn's Disease)
06/2018 - 01/2012
4Neoplasm Metastasis (Metastasis)
06/2022 - 08/2008
4Adenocarcinoma
02/2022 - 09/2017
4Ulcerative Colitis
11/2021 - 04/2011
4Carcinoma (Carcinomatosis)
03/2015 - 01/2009
3Hemorrhage
01/2022 - 07/2011
3Infections
06/2018 - 01/2011
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2013 - 02/2010
2Adenoma (Adenomas)
02/2022 - 09/2017
2Carcinogenesis
01/2022 - 03/2015
2Pain (Aches)
07/2021 - 06/2018
2Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 01/2018
2Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2018 - 01/2011
2Ulcer
06/2018 - 11/2007
2Leukemia
01/2013 - 01/2010
1Muscular Dystrophies (Muscular Dystrophy)
06/2022
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021
1Esophageal Squamous Cell Carcinoma
01/2021
1Polyps
09/2017
1Paraganglioma (Paragangliomas)
06/2017
1Necrosis
07/2016

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2013
5ErbB Receptors (EGF Receptor)IBA
12/2022 - 06/2008
5Adalimumab (Humira)FDA Link
06/2017 - 01/2012
5Epidermal Growth Factor (EGF)IBA
01/2013 - 06/2008
5Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
01/2013 - 06/2008
4Cisplatin (Platino)FDA LinkGeneric
12/2022 - 06/2009
4MicroRNAs (MicroRNA)IBA
01/2022 - 12/2019
4Photosensitizing Agents (Photosensitizers)IBA
01/2021 - 07/2016
4Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2009
3Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2022 - 03/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 03/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 02/2010
3LigandsIBA
03/2013 - 11/2011
3Biological ProductsIBA
04/2012 - 01/2009
3Fluorouracil (Carac)FDA LinkGeneric
03/2011 - 08/2008
2Trastuzumab (Herceptin)FDA Link
12/2022 - 01/2016
2Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 01/2010
2Ustekinumab (CNTO 1275)FDA Link
11/2021 - 06/2018
2AcidsIBA
01/2021 - 01/2011
2phytochlorinIBA
08/2019 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
08/2019 - 01/2018
2chlorinIBA
08/2019 - 07/2016
2Bevacizumab (Avastin)FDA Link
01/2019 - 03/2011
2Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 10/2011
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018 - 07/2016
2AntibodiesIBA
09/2017 - 03/2013
2Infliximab (Remicade)FDA Link
05/2016 - 06/2013
2Tacrolimus (Prograf)FDA LinkGeneric
06/2013 - 04/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
06/2013 - 04/2011
2Cell Adhesion Molecule-1IBA
03/2011 - 02/2010
2Proton Pump InhibitorsIBA
01/2011 - 01/2011
2GastrinsIBA
01/2011 - 01/2009
2LentinanIBA
03/2009 - 01/2009
1Glycerol (Glycerine)FDA LinkGeneric
06/2022
1Dystroglycans (Dystroglycan)IBA
06/2022
1Polysaccharides (Glycans)IBA
06/2022
1Phosphates (Orthophosphate)IBA
06/2022
1Calcibiotic Root Canal SealerIBA
02/2022
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2022
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2022
1Estrogens (Estrogen)FDA Link
01/2022
1Phenobarbital (Luminal)FDA Link
07/2021
1protoporphyrin IXIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
11/2020
1CytokinesIBA
01/2020
1tofacitinibIBA
01/2020
1Janus KinasesIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Janus Kinase InhibitorsIBA
01/2020
1Talaporfin (talaporfin sodium)IBA
08/2019
1Trefoil Factor-3IBA
03/2019
1Cysteine-Rich Protein 61IBA
03/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1RamucirumabIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019
1AntralIBA
06/2018
1Singlet OxygenIBA
01/2018
1SugarsIBA
01/2018
1Tissue Kallikreins (Tissue Kallikrein)IBA
04/2017
1Histones (Histone)IBA
11/2016
1PlatinumIBA
11/2016
1DNA (Deoxyribonucleic Acid)IBA
11/2016
1Oxygen (Dioxygen)IBA
07/2016

Therapy/Procedure

17Therapeutics
12/2022 - 06/2008
15Drug Therapy (Chemotherapy)
01/2019 - 08/2008
5Blood Component Removal (Apheresis)
11/2021 - 04/2011
3Photochemotherapy (Photodynamic Therapy)
08/2019 - 07/2016
3Gastrectomy
05/2012 - 10/2009
2Lasers (Laser)
01/2021 - 07/2010
2Combination Drug Therapy (Combination Chemotherapy)
06/2009 - 01/2009
1Sutures (Suture)
02/2022
1Ligation
12/2018
1Remission Induction
06/2018